872002-72-7Relevant articles and documents
Discovery of 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin- 1-yl}methyl)quinoxaline(WAY-207024): An orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)
Pelletier, Jeffrey C.,Chengalvala, Murty V.,Cottom, Joshua E.,Feingold, Irene B.,Green, Daniel M.,Hauze, Diane B.,Huselton, Christine A.,Jetter, James W.,Kopf, Gregory S.,Lundquist, Joseph T.,Magolda, Ronald L.,Mann, Charles W.,Mehlmann, John F.,Rogers, John F.,Shanno, Linda K.,Adams, William R.,Tio, Cesario O.,Wrobel, Jay E.
supporting information; experimental part, p. 2148 - 2152 (2009/12/31)
A potent, highly insoluble, GnRH antagonist with a 2-phenyl-4- piperazinylbenzimidazole template and a quinoxaline-2,3-dione pharmacophore was modified to maintain GnRH antagonist activity and improve in vitro pharmaceutical properties. Structural changes
Gonadotropin releasing hormone receptor antagonists
-
Page/Page column 36, (2010/02/15)
The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.
Processes for preparing gonadotropin releasing hormone receptor antagonists
-
Page/Page column 18, (2008/06/13)
The present invention relates to methods of making Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.